-
Mashup Score: 1Do We Really Know the Stroke Risk From AF? - 12 day(s) ago
There is growing evidence that the risk for stroke in patients with untreated AF is declining, changing the risk-benefit calculus for anticoagulation.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Point-of-Care Medical Reference App For Doctors | Medscape - 13 day(s) ago
Check drug interactions, access 450+ medical calculators, and ID pills at the point-of-care with Medscape’s official app. No hidden costs or subscription fees.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
Need fast drug and condition search results? Try our AI-powered search assistant, now available in the Medscape app for US users: https://t.co/sj0Bjx3CNe https://t.co/qlRdFnR4I4
-
-
Mashup Score: 5Clinical Mistakes Med Students Make and How to Avoid Them - 13 day(s) ago
Medical students often make key mistakes during clinical rotations, such as being too focused on technical tasks. Most importantly, they should prioritize patient care.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
Medical students often make key mistakes during clinical rotations, such as being too focused on technical tasks. Most importantly, they should prioritize patient care. https://t.co/H9Mj31OGXk
-
-
Mashup Score: 241
A trial suggests that patients with asymptomatic severe aortic stenosis should undergo early transcatheter aortic valve implantation, but John Mandrola, MD, sees flaws in the study design.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
I'm not sure which will be worse, EARLY TAVR or OPTION. Med science is for asking important questions--not designing trials to be positive My take on EARLY TAVR is up. It's quite sad. https://t.co/mMRfvkYdcj
-
-
Mashup Score: 6Promise for CAR T-Cell Therapies in Solid Tumors? - 14 day(s) ago
CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in targeting solid tumors have been limited.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in targeting solid tumors have been limited. https://t.co/EEypwfXNou
-
-
Mashup Score: 0HPV Vaccine ‘Very Promising’ for Nixing Precancerous Lesions - 14 day(s) ago
A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some patients.
Source: www.medscape.comCategories: General Medicine News, Infectious DiseaseTweet-
“The rSFVeE6,7 vaccine (Vvax001) targets tumor-specific antigens E6 and E7, which are over-expressed in HPV16 — the infection most commonly linked to premalignant and malignant cervical lesions.” https://t.co/DGHavEyHeu
-
-
Mashup Score: 22
A growing body of research suggests that regular coffee drinking can lower the risk for liver, endometrial, and colorectal cancers.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
A growing body of research suggests that regular coffee drinking can lower the risk for liver, endometrial, and colorectal cancers. https://t.co/9XBYLslsZH
-
-
Mashup Score: 3Considerations for Prescribing GLP-1s Get More Complicated - 14 day(s) ago
New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
Considerations for Prescribing GLP-1s Get More Complicated, says @zalaly et al study https://t.co/4T2dY027Ko via @sarafnovak
-
-
Mashup Score: 3Considerations for Prescribing GLP-1s Get More Complicated - 14 day(s) ago
New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
Considerations for Prescribing GLP-1s Get More Complicated, says @zalaly et al study https://t.co/4T2dY027Ko via @sarafnovak
-
-
Mashup Score: 1New Pill Successfully Lowers Lp(a) Levels - 14 day(s) ago
Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk and for which no approved therapies currently exist.
Source: www.medscape.comCategories: General Medicine News, CardiologistsTweet-
1st Pill to Effectively Lower Lp(a) Levels https://t.co/XdUhWdixrt
-
Do We Really Know the Stroke Risk From AF? https://t.co/BVfqSJ4zI3 via @drjohnm